Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Microglia drive diurnal variation in susceptibility to inflammatory blood-brain barrier breakdown
Jennifer H. Lawrence, Asha Patel, Melvin W. King, Collin J. Nadarajah, Richard Daneman, Erik S. Musiek
Jennifer H. Lawrence, Asha Patel, Melvin W. King, Collin J. Nadarajah, Richard Daneman, Erik S. Musiek
View: Text | PDF
Research Article Inflammation Neuroscience

Microglia drive diurnal variation in susceptibility to inflammatory blood-brain barrier breakdown

  • Text
  • PDF
Abstract

The blood-brain barrier (BBB) is critical for maintaining brain homeostasis but is susceptible to inflammatory dysfunction. While transporter-dependent efflux of some lipophilic substrates across the BBB shows circadian variation due to rhythmic transporter expression, basal transporter–independent permeability and leakage is nonrhythmic. Whether daily timing influences BBB permeability in response to inflammation is unknown. Here, we induced systemic inflammation through repeated LPS injections either in the morning (ZT1) or evening (ZT13) under standard lighting conditions; we then examined BBB permeability to a polar molecule that is not a transporter substrate, sodium fluorescein. We observed clear diurnal variation in inflammatory BBB permeability, with a striking increase in paracellular leak across the BBB specifically following evening LPS injection. Evening LPS led to persisting glia activation as well as inflammation in the brain that was not observed in the periphery. The exaggerated evening neuroinflammation and BBB disruption were suppressed by microglial depletion or through keeping mice in constant darkness. Our data show that diurnal rhythms in microglial inflammatory responses to LPS drive daily variability in BBB breakdown and reveal time of day as a key regulator of inflammatory BBB disruption.

Authors

Jennifer H. Lawrence, Asha Patel, Melvin W. King, Collin J. Nadarajah, Richard Daneman, Erik S. Musiek

×

Figure 5

Persisting neuroinflammation after evening LPS exposure specifically enhances BBB-related gene expression.

Options: View larger image (or click on image) Download as PowerPoint
Persisting neuroinflammation after evening LPS exposure specifically enh...
(A) Volcano plot of differentially expressed genes (DEGs) from bulk RNA-Seq in LPS-treated mouse cortex, comparing ZT1 versus ZT13 treatment time. Red dots indicate transcripts with adjusted P < 0.05 and fold change > 1.75-fold; right upper area indicates higher expression in mice treated at ZT13. (B) Venn diagram showing overlap of DEGs upregulated hpi in the ZT1 versus ZT13 datasets. (C) Scatter plot of genes with a significant TOD and treated interaction by 2-way ANOVA. Log fold change (PBS versus LPS) in the a.m. (ZT1) group is shown on x axis and in the p.m. (ZT13) group on y axis. Illustrations indicate the response of genes in that area to LPS (up or down arrow) in the a.m. (sun) or p.m. (moon). Genes shown above the red dotted line and right of the y axis were all upregulated in the p.m., with Nos2 being the highest fold change. (D) ORA dotplot of the top dysregulated KEGG pathways using the full gene list from D. n = 3–5 mice per group.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts